Mycology Research Cordyceps MRL 500mg 90 tablets

Mycology Research Cordyceps MRL 500mg tablets

Cordyceps sinensis is derived from a master strain of Cordyceps sourced from Nepal. The powder contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate. This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardised production of Cordyceps sinensis. The powder biomass is then sealed in plastic containers.
Unlike Cordyceps sourced from the Far East the MRL raw material is not harvested from dead caterpillar but rather is grown on a sterile culture medium. Thus the possibility of contamination by harmful bacteria or fungi is eliminated.
Manufacturing Process of Cordyceps-MRL The Cordyceps sinensis is processed under the same rigorously controlled conditions that are applied to the manufacture of a conventional pharmaceutical. This ensures that each tablet contains 500 mg of the standardised Cordyceps product.
The tablets are film coated to protect them from moisture, thus preserving the quality of the product and ensuring a long shelf life.
After passing quality control testing the tablets are released for use. The choice of additives used in the production renders these tablets suitable for Kosher or vegetarian use.